Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.46

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.30

Views

Views
January 20250
February 20251
March 202515
April 20252
May 20253
June 20257
July 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong8
United States4
United Kingdom2
Spain1
 

Top cities views

Views
Hong Kong8
Council Bluffs1
Racine1